Mr. Papandrea has over 25 years of healthcare and life science industry experience with involvement in the global healthcare market in consultative, product, IT solution, entrepreneurial and sales execution arenas. He has held leadership roles at Ernst & Young, Deloitte, and SAP, where he was head of the Global Health Science Business. Most recently, he was the CEO of Willowglade Technologies. Mr. Papandrea received a BAppSc. in Biomedical Science from University of Technology Sydney, Australia and a M.H.A. in Health Administration from the University of New South Wales, Australia.
A graduate of Stanford University in Mechanical Engineering, Mr. Hermann began his medical device career in 1983 working directly with surgeon inventor and entrepreneur Thomas Fogarty, MD. During his 18 year tenure with Dr. Fogarty and thereafter, Mr. Hermann has been operationally responsible for the development of more than 20 commercially successful medical product families in urology, cardiac and vascular surgery, general surgery, radiology, radiation oncology and women’s health. He has been a founder, board member and/or president of a variety of medical device startups that were acquired by Medtronic, Covidien, Johnson & Johnson, Hologic, Microline Pentax and Varian Medical Systems. Mr. Hermann is an inventor on more than 200 patents and patent applications and is an author of more than 50 scientific presentations on medical device technology.
Mr. Cousins has more than 30 years of experience in public accounting and senior financial executive roles, primarily with venture capital backed medical device companies. From January 2014 he served as Chief Financial Officer of Sequent Medical until its acquisition by MicroVention/Terumo in July 2016 and assisted with integration activities until April 2017. Mr. Cousins served as Chief Financial Officer at Neomend from September 2010 until its acquisition by Davol/CR Bard in October of 2012. From May 2001 to July 2010, he served as Chief Financial Officer of SenoRx. In March 2007 SenoRx completed its IPO and was subsequently acquired by CR Bard in July 2010. Mr. Cousins also served in other senior financial roles with Sonendo, Intralase, BBI Source Scientific and Biopsys Medical. He began his professional career with KPMG and earned his license as a Certified Public Accountant in 1980. Mr. Cousins earned his B.A. in Business Administration from California State University, Fullerton, and his M.S. in Taxation from Golden Gate University.
Recognized internationally for her pioneering clinical work as an oncoplastic breast surgeon, Dr. Lebovic has collaborated with Mr. Hermann and Dr. Fogarty on a variety of projects in the field of women’s healthcare. She has served as founder/board member/medical director and consultant for many medical device companies and has a long track record of successful commercialization and acceptance of products into clinical practice. She is well known as an inventor of the MammoPad® breast cushion as well as other popular, innovative devices. Dr. Lebovic spent 12 years as an attending surgeon at Stanford University Medical Center and later served as Associate Director of the Lee Breast Center at USC and Director of Women’s Healthcare at the Cooper Clinic in Dallas, Texas. She has lectured extensively throughout the world, and has authored numerous scientific publications. Her leadership roles in various philanthropic endeavors have been an important part of her career, and she has recently completed a two-year term as President of the American Society of Breast Disease.